Evidence map›Paper›PMID 42060644›Full record

ArticlePloS one2026

Comparative evaluation of the healing potential of excision wound using Nano- formulations of silver, gold, or their mixture: In-silico and in vivo approaches.

Abeer A Mabrouk, Sameh H Ismail, Ahmed G Soliman, Mervat M Omran

Abstract readComparative Study
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abeer A MabroukDepartment of Biochemistry, Egyptian Drug Authority (NODCAR), Cairo, Egypt.
Sameh H IsmailEgypt Nanotechnology Centre, Cairo University, El-Sheikh Zayed, Giza, Egypt.
Ahmed G SolimanAgricultural Biochemistry Department, Faculty of Agriculture, Ain Shams University, Shoubra El-Kheima, Cairo, Egypt.ORCID https://orcid.org/0000-0002-1122-3993
Mervat M OmranCancer Biology Department, National Cancer Institute - Cairo University, Cairo, Egypt.ORCID https://orcid.org/0000-0003-1643-0104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medical use of metal nanoparticles is recommended to reduce adverse effects and improve curative action when compared to their pure ions. Current research discussed the healing effect of topical formulations of silver, gold, and their mixtures of nanoparticles on excision wounds in rat models. The physicochemical factors of the prepared nanoparticles were measured by dynamic light scattering (DLS), Zeta potential, atomic force microscopy (AFM), and transmission electron microscopy (TEM). Thirty-two albino rats were divided into six groups: wound untreated, silver nanoparticles (AgNps) treated, gold nanoparticles (AuNps), silver-gold nanoparticles (Ag/AuNps 1:1) mixture treated, and fusidic acid (reference drug) treated groups, respectively. Management was performed daily for 21 days. In all groups, the percentages of contraction area and histological investigation of the wound area were investigated. Myeloperoxidase (MPO), nitric oxide (NO), vascular endothelial growth factor (VEGF), hydroxyproline, hexosamine, and collagen deposition using Masson's trichrome stain (MT) as a biomarker of wound healing activity were measured. An in-silico study investigated the molecular interaction of the metal nanoformulations with various protease enzymes involved in inflammation and the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of the examined metals. The AgNPs and AuNPs have efficient wound-repairing activity, as evident from the wound shrinkage and enhanced wound healing. Metal nanoformulations have effective wound healing activity by enhancing angiogenesis and collagen formation.

Indexed as

GoldMetal NanoparticlesSilverWound HealingAnimalsCollagenHexosaminesHydroxyprolineMaleNitric OxidePeroxidaseRatsVascular Endothelial Growth Factor ACollagenGoldHexosaminesHydroxyprolineNitric OxidePeroxidaseSilverVascular Endothelial Growth Factor A

Identifiers

PMID42060644
PMCPMC13132192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.